CVS Health Corporation Company Profile (NYSE:CVS)

About CVS Health Corporation (NYSE:CVS)

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites,, and, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Drug Retailers - NEC
  • Sub-Industry: Drug Retail
  • Symbol: NYSE:CVS
  • CUSIP: 12665010
  • Web:
  • Market Cap: $80.19681 billion
  • Outstanding Shares: 1,016,564,000
Average Prices:
  • 50 Day Moving Avg: $78.68
  • 200 Day Moving Avg: $78.94
  • 52 Week Range: $69.30 - $98.44
  • Trailing P/E Ratio: 15.47
  • Foreward P/E Ratio: 12.23
  • P/E Growth: 1.67
Sales & Book Value:
  • Annual Revenue: $180.79 billion
  • Price / Sales: 0.44
  • Book Value: $33.64 per share
  • Price / Book: 2.31
  • Annual Dividend: $2.00
  • Dividend Yield: 2.5%
  • EBIDTA: $12.65 billion
  • Net Margins: 2.93%
  • Return on Equity: 17.47%
  • Return on Assets: 6.58%
  • Debt-to-Equity Ratio: 0.75%
  • Current Ratio: 1.09%
  • Quick Ratio: 0.56%
  • Average Volume: 5.61 million shs.
  • Beta: 0.91
  • Short Ratio: 3.89

Frequently Asked Questions for CVS Health Corporation (NYSE:CVS)

What is CVS Health Corporation's stock symbol?

CVS Health Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health Corporation pay dividends? What is the dividend yield for CVS Health Corporation?

CVS Health Corporation declared a quarterly dividend on Thursday, July 6th. Shareholders of record on Monday, July 24th will be given a dividend of $0.50 per share on Thursday, August 3rd. This represents a $2.00 annualized dividend and a yield of 2.58%. The ex-dividend date of this dividend is Thursday, July 20th. View CVS Health Corporation's Dividend History.

How were CVS Health Corporation's earnings last quarter?

CVS Health Corporation (NYSE:CVS) issued its quarterly earnings results on Tuesday, August, 8th. The company reported $1.33 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.31 by $0.02. The business earned $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The company's revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.32 earnings per share. View CVS Health Corporation's Earnings History.

When will CVS Health Corporation make its next earnings announcement?

CVS Health Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, November, 14th 2017. View Earnings Estimates for CVS Health Corporation.

What guidance has CVS Health Corporation issued on next quarter's earnings?

CVS Health Corporation updated its FY17 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of $5.83-5.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.87. CVS Health Corporation also updated its Q3 guidance to $1.47-1.50 EPS.

Where is CVS Health Corporation's stock going? Where will CVS Health Corporation's stock price be in 2017?

19 brokers have issued 1-year target prices for CVS Health Corporation's stock. Their forecasts range from $82.00 to $111.00. On average, they expect CVS Health Corporation's stock price to reach $91.57 in the next twelve months. View Analyst Ratings for CVS Health Corporation.

What are analysts saying about CVS Health Corporation stock?

Here are some recent quotes from research analysts about CVS Health Corporation stock:

  • 1. Guggenheim analysts commented, " Our recent meetings with CEO Larry Merlo, CFO Dave Denton, and VP-IR Nancy Christal further reinforced our confidence in 10% secular growth, which we believe the market is currently undervaluing, at a 13x P/E on somewhat depressed 2017E EPS. Bottom line, even in the face of secular gross margin erosion, in both segments, we believe the company should be able to grow EBIT by 5% on the back of a) natural growth in specialty Rx, b) increasingly rapid product innovation, c) a broadening set of productive relationships, and d) both COGS and SG&A reductions. In our view, this growth merits a valuation closer to a market multiple'we reiterate our Buy rating and $90 PT, implying 15% upside from current levels." (3/28/2017)
  • 2. Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)

Who are some of CVS Health Corporation's key competitors?

Who are CVS Health Corporation's key executives?

CVS Health Corporation's management team includes the folowing people:

  • David Wyatt Dorman, Independent Chairman of the Board
  • Larry J. Merlo, President, Chief Executive Officer, Director
  • David M. Denton, Chief Financial Officer, Executive Vice President
  • Jonathan C. Roberts, Chief Operating Officer, Executive Vice President
  • Lisa G. Bisaccia, Chief Human Resource Officer, Executive Vice President
  • Stephen J. Gold, Executive Vice President, Chief Information Officer
  • Thomas M. Moriarty, Executive Vice President, General Counsel, Chief Health Strategy Officer
  • Troyen A. Brennan M.D., Executive Vice President, Chief Medical Officer
  • Helena B. Foulkes, Executive Vice President, President of CVS - Pharmacy
  • J. David Joyner, Executive Vice President

Who owns CVS Health Corporation stock?

CVS Health Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.51%), BlackRock Inc. (6.05%), State Street Corp (4.30%), FMR LLC (2.96%), Northern Trust Corp (1.53%) and Nordea Investment Management AB (1.39%). Company insiders that own CVS Health Corporation stock include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Stephen J Gold and Troyen A Brennan. View Institutional Ownership Trends for CVS Health Corporation.

Who sold CVS Health Corporation stock? Who is selling CVS Health Corporation stock?

CVS Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Arrowstreet Capital Limited Partnership, BlackRock Inc., Ameriprise Financial Inc., Pioneer Investment Management Inc., TIAA CREF Investment Management LLC, Bank of New York Mellon Corp and Alliancebernstein L.P.. Company insiders that have sold CVS Health Corporation stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Richard J Swift and Troyen A Brennan. View Insider Buying and Selling for CVS Health Corporation.

Who bought CVS Health Corporation stock? Who is buying CVS Health Corporation stock?

CVS Health Corporation's stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Boston Partners, Parametric Portfolio Associates LLC, Prudential Financial Inc., Nordea Investment Management AB, Vanguard Group Inc., Brandywine Global Investment Management LLC and Canada Pension Plan Investment Board. View Insider Buying and Selling for CVS Health Corporation.

How do I buy CVS Health Corporation stock?

Shares of CVS Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health Corporation's stock price today?

One share of CVS Health Corporation stock can currently be purchased for approximately $77.66.

MarketBeat Community Rating for CVS Health Corporation (NYSE CVS)
Community Ranking:  3.6 out of 5 (  )
Outperform Votes:  819 (Vote Outperform)
Underperform Votes:  317 (Vote Underperform)
Total Votes:  1,136
MarketBeat's community ratings are surveys of what our community members think about CVS Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $91.57 (17.91% upside)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/17/2017Citigroup Inc.Lower Price TargetNeutral$88.00 -> $87.00LowView Rating Details
8/14/2017Robert W. BairdReiterated RatingOutperform$90.00LowView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform -> Market Perform$89.00 -> $82.00LowView Rating Details
7/14/2017Jefferies Group LLCReiterated RatingHold$82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
6/27/2017Needham & Company LLCInitiated CoverageHold -> HoldLowView Rating Details
6/27/2017Leerink SwannSet Price TargetBuy$90.00N/AView Rating Details
6/13/2017Cowen and CompanyReiterated RatingOutperform$86.00LowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
4/27/2017Tigress FinancialInitiated CoverageBuy -> BuyLowView Rating Details
2/28/2017Bank of America CorporationReiterated RatingBuy$106.67N/AView Rating Details
2/8/2017Deutsche Bank AGReiterated RatingHold$88.00N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
12/18/2016Oppenheimer Holdings, Inc.Set Price TargetBuy$88.00N/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016Barclays PLCReiterated RatingBuy$85.00N/AView Rating Details
11/9/2016MizuhoBoost Price TargetBuy$90.00 -> $111.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
5/4/2016Royal Bank Of CanadaReiterated RatingOutperform$110.00 -> $115.00N/AView Rating Details
2/10/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$106.00 -> $110.00N/AView Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00N/AView Rating Details
11/2/2015Raymond James Financial, Inc.Boost Price TargetOutperform$105.00 -> $110.00N/AView Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00N/AView Rating Details
11/2/2015J P Morgan Chase & CoLower Price TargetOverweight$128.00 -> $123.00N/AView Rating Details
(Data available from 8/19/2015 forward)


Earnings History for CVS Health Corporation (NYSE:CVS)
Earnings by Quarter for CVS Health Corporation (NYSE:CVS)
Earnings History by Quarter for CVS Health Corporation (NYSE CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017$1.49N/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.36 billion$45.69 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corporation (NYSE:CVS)
2017 EPS Consensus Estimate: $5.86
2018 EPS Consensus Estimate: $6.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.09$1.33$1.18
Q2 20174$1.30$1.32$1.31
Q3 20175$1.47$1.64$1.51
Q4 20175$1.71$1.91$1.85
Q1 20184$1.12$1.49$1.30
Q2 20184$1.43$1.62$1.48
Q3 20183$1.65$1.82$1.73
Q4 20183$1.89$2.05$1.98
Q1 20191$1.24$1.24$1.24
Q2 20191$1.59$1.59$1.59
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Most Recent Dividend:8/3/2017
Annual Dividend:$2.00
Dividend Yield:2.58%
Dividend Growth:23.60% (3 Year Average)
Payout Ratio:39.92% (Trailing 12 Months of Earnings)
34.01% (Based on This Year's Estimates)
31.50% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for CVS Health Corporation (NYSE:CVS)

Dividend History by Quarter for CVS Health Corporation (NYSE CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CVS Health Corporation (NYSE:CVS)
Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 82.31%
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.00View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.00View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.36View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.77View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.40View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.60View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.00View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CVS Health Corporation (NYSE:CVS)
Latest Headlines for CVS Health Corporation (NYSE:CVS)
DateHeadline logoThis Bottoming Healthcare Stock Just Narrowed Its Guidance - Seeking Alpha - August 18 at 10:45 PM logoCVS Health Corporation (CVS) Director Sells $199,050.00 in Stock - August 18 at 8:08 PM logoCVS Health Corporation 2017 Q2 - Results - Earnings Call Slides - August 18 at 5:43 PM logoCVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : August 18, 2017 - August 18 at 5:42 PM logoLet’s Explore How Cost Leadership Provides Market Control - August 18 at 5:42 PM logoKao Corporation: What’s Sharpening Its Competitive Edge? - August 18 at 5:42 PM logoCitigroup Inc. Lowers CVS Health Corporation (CVS) Price Target to $87.00 - August 17 at 5:32 PM logoCVS Pharmacy Earns URAC Reaccreditation in Community Pharmacy - August 17 at 4:30 PM logoCVS Health Survey Reveals Two in Three Americans who plan to get a Flu Shot Believe it is the Best Way to Prevent the Flu - August 16 at 11:06 PM logoCVS Is Going Back Towards $100 - Seeking Alpha - August 16 at 6:05 PM logoExpress Scripts to limit opioids; doctors concerned - August 16 at 2:23 PM logoIs It Time To Buy CVS? - Seeking Alpha - August 15 at 4:04 AM logoCVS Health Corporation (CVS) Receives Outperform Rating from Robert W. Baird - August 14 at 11:48 PM logoCVS Health: Enticing Yield - Seeking Alpha - August 14 at 6:01 PM logoCVS Health Corporation (NYSE:CVS) to Post FY2017 Earnings of $5.85 Per Share, Leerink Swann Forecasts - August 14 at 5:52 AM logoQ3 2017 EPS Estimates for CVS Health Corporation Reduced by Needham & (CVS) - August 14 at 3:18 AM logoCVS Dividend Remains Safe - Q2 2017 Update - August 13 at 4:49 PM logoFaruqi & Faruqi, LLP is Investigating CVS Health Corporation (CVS) on Behalf of its Shareholders - PR Newswire (press release) - August 12 at 10:09 PM logoSee what the IHS Markit Score report has to say about CVS Health Corp. - August 12 at 5:05 PM logoCVS Has a Top Secret Plan in the Works to Help Ease Your Depression - August 12 at 5:05 PM logoFaruqi & Faruqi, LLP is Investigating CVS Health Corporation (CVS) on Behalf of its Shareholders - August 11 at 6:07 PM logoMcKesson Corporation (MCK) vs. CVS Health Corporation (CVS) Financial Analysis - August 11 at 4:58 PM logoCVS Health Corporation (NYSE:CVS) Forecasted to Earn Q3 2017 Earnings of $1.49 Per Share - August 11 at 9:26 AM logoCVS's Second Quarter: A Tale Of Two Segments - August 10 at 11:59 PM logoIHS Markit Score downgrades CVS Health Corp to 64 out of 100, ranking positively in only one out of three available IHS Markit categories. - August 10 at 6:55 PM logoCVS Health Corp. :CVS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017 - August 10 at 6:55 PM logoAmazon Could Probably Conquer Drugstores, Too - August 10 at 6:55 PM logoQ3 2017 EPS Estimates for CVS Health Corporation (NYSE:CVS) Reduced by Oppenheimer Holdings - August 10 at 12:04 PM logoCVS Health Corporation to Post Q3 2017 Earnings of $1.49 Per Share, SunTrust Banks Forecasts (NYSE:CVS) - August 10 at 12:04 PM logoCVS Health Corporation Sees Unusually Large Options Volume (NYSE:CVS) - August 10 at 7:54 AM logoInvestors Buy Large Volume of Call Options on CVS Health Corporation (NYSE:CVS) - August 10 at 7:54 AM logoDoes CVS Jack Up Drug Costs If You Have Insurance? - August 9 at 10:55 PM logoCVS Health (CVS) Q2 2017 Results - Earnings Call Transcript - August 9 at 10:55 PM logoToday's Research Reports on Trending Tickers: Rite Aid and CVS Health Corporation - August 9 at 10:55 PM logoTop Stock Reports for CVS Health, Marriott & Enbridge - August 9 at 10:55 PM logoCVS Charges More for Generic Drugs Paid for With Insurance, Lawsuit Claims - - August 9 at 5:53 PM logoCVS Health Corp. – Value Analysis (NYSE:CVS) : August 9, 2017 - August 9 at 5:53 PM logoFY2017 Earnings Estimate for CVS Health Corporation (CVS) Issued By Oppenheimer Holdings - August 9 at 8:54 AM logoCVS Moves Deeper Into Doctors’ Turf - August 8 at 10:25 PM logoAmazon to Eventually Topple CVS? - August 8 at 10:25 PM logoEdited Transcript of CVS earnings conference call or presentation 8-Aug-17 12:30pm GMT - August 8 at 10:25 PM logo[$$] CVS Moves Deeper Into Doctors’ Turf - August 8 at 10:25 PM logoBRIEF-CVS Health reports Q2 GAAP earnings per share $1.07 from continuing operations - Reuters - August 8 at 5:24 PM logoCVS Health's quarterly profit jumps 19 pct - Reuters - August 8 at 5:24 PM logoCVS Health shares rise after earnings and revenue beat estimates - MarketWatch - August 8 at 5:24 PM
News IconCVS beats across the board - Business Insider - August 8 at 5:24 PM logoCVS Health Is Sued Over 'Clawbacks' of Prescription Drug Co-Pays - Bloomberg - August 8 at 5:23 PM logoCVS: Cash Flow King - Seeking Alpha - August 8 at 5:23 PM logoCVS Health Corporation's PBM Strong, but Retail Business Weak in 2nd Quarter - Motley Fool - August 8 at 5:23 PM logoCVS Health Corporation's PBM Strong, but Retail Business Weak in 2nd Quarter - August 8 at 5:23 PM



CVS Health Corporation (CVS) Chart for Saturday, August, 19, 2017

This page was last updated on 8/19/2017 by Staff